Abstract
A 63-year old, obese lady is seen by her doctor because of atypical chest pain (Figure 9-1) (see Color Plates section). She has a history of diabetes, hypertension, and mildly elevated cholesterol levels, and her electrocardiogram (ECG) is consistent with left ventricular hypertrophy. Her private physician believes in performing the cheapest, least invasive test first. He orders a stress ECG ($330). The ECG is positive (1.5 mm of horizontal ST depression) at 6 min of a modified stress test. Because there is a history of hypertension and left ventricular hypertrophy on ECG, the significance of the “abnormality” on the stress ECG is questioned by the physician, who then decides a radionuclide stress test might add more certainty to the diagnosis. Exercise 201Tl SPECT imaging ($1200) is then performed, but the presence of attenuation caused by breast tissue causes an “equivocal” interpretation. At this point, cardiac catheterization is performed ($4800) and the patient is found to have normal coronary arteries at a total cost of $6330 for all three procedures. Had this physician obtained a positron emission tomography (PET) MPI after the equivocal 201Tl, the negative result would have saved 53% or $3300 ($6330–$3000). If a PET had been obtained in this woman as the first test, the savings would have been 72% or $4530.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pichard AD. Coronary arteriography: For everyone? Am J Cardiol 38:533–535, 1976.
Ellwood. Shattuck Guest Lecture—Outcome management. A technology of patient experience. N Engl J Med 18:1549, 1988.
Gould KL. PET perfusion imaging and nuclear cardiology. J Nucl Med 32:579–606, 1991.
Gould KL, Goldstein RA, Mullani NA, et al. Noninvasive assessment of coronary stenosis by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82. J Am Coll Cardiol 7:755–789, 1986.
Demer LL, Gould KL, Goldstein RA, et al. Assessment of coronary artery disease severity by positron emission tomography: Comparison with quantitative arteriography in 193 patients. Circulation 79:825–835, 1989.
Williams BR, Jansen DE, Wong LF, et al. Positron emission tomography for the diagnosis of coronary artery disease: A non-university experience and correlation with coronary angiography (abstr). J Myocard Isch 2:38, 1990.
Tamaki N, Yonekura Y, Senda M, et al. Value and limitation of stress thallium-201 single photon emission computed tomography: Comparison with nitrogen-13 ammonia positron tomography. J Nucl Med 29:1181–1188, 1988.
Stewart RE, Schwaiger M, Molina E, et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 67:1303–1310, 1991.
Go RT, Marwick TH, Maclntyre WJ, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 31:1899–1905, 1990.
MacIntyre WJ, Go RT, King JL, et al. Clinical outcome of cardiac patients with negative thallium-201 SPECT and positive rubidium-82 PET myocardial perfusion imaging. J Nucl Med 34:400–404, 1993.
Schwaiger M, Hutchins G. Qualitative and quantitative assessment of perfusion imaging: Evaluation of coronary flow by PET. Am J Cardiac Imaging 5(Suppl 1):26–31, 1991.
Schelbert HR, Wisenberg G, Phelps ME, et al. Noninvasive assessment of coronary vasodilation: VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography. Am J Cardiol 49:1197–1207, 1982.
Gupta NC, Esterbrooks D, Mohiuddin S, et al. Adenosine and myocardial perfusion imaging using positron emission topmography. Am Heart J 122:293–301, 1991.
Yonekura Y, Tamaki N, Senda M, et al. Detection of coronary artery disease with 13N-ammonia and high-resolution positron-emission ocmputed tomography. Am Heart J 113: 645–653, 1987.
DePasquale EE, Nody AC, DePuey EG, et al. Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease. Circulation 77:316–327, 1988.
Van Train KF, Berman DS, Garcia EV, et al. Quantitative analysis of stress thallium-201 myocardial scintigrams: A multicenter trial. J Nucl Med 27:17–25, 1986.
Iskandrian AS, Heo J, Kong B, et al. Effective of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: Analysis of 461 patients. J Am Coll Cardiol 14:1477–1486, 1989.
Schwartz RS, Jackson WG, Celio PV, et al. Exercise thallium-201 scintigraphy for detecting coronary artery disease in asymptomatic young men. J Am Coll Cardiol 11:80A, 1988.
Ranhosky A, Gerlag DM. Quantitative interpretation provides no advan tages over qualitative interpretation in intravenous dipyridamole thallium imaging. Circulation 78: II-432, 1988.
Bungo MW, Leland OS. Discordance of exercise thallium testing with coronary arteriography in patients with atypical presentations. Chest 83:112–116, 1983.
Van Train KF, Maddahi J, Berman DS, et al. Quantitative analysis of tomographic stress thallium-201 myocardial scintigrams: A multicenter trial. J Nucl Med 31:1168–1179, 1990.
Patterson RE, Eng C, Horowitz SF, Gorlin R, Goldstein ST. Bayesian comparison of cost-effectiveness of different clinical approaches to diagnose coronary artery disease. J Am Coll Cardiol 4:278–289, 1984.
Patterson RE, Eisner RL, Horowitz SF. Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and angiography for diagnosis of coronary artery disease. Circulation 91:54–65, 1995.
Patterson RE, Eisner RL, Chu TH, Horowitz SF. Comparison of factors that influence cost-effectiveness of diagnosis and management of coronary disease: Test fee vs. quality of care for PET vs. SPECT (abstr). J Nucl Med 34:36p, 1993.
Patterson RE, Eng C, Horowitz SF. Practical diagnosis of coronary arterial disease: A Bayes’ theorem nomogram to correlate clinical data with noninvasive exercise tests. Am J Cardiol 53:252–256, 1984.
Patterson RE, Horowitz SF. Importance of epidemiology and biostatistics in deciding clinical strategies for using diagnostic tests: A simplified approach using examples from coronary artery disease. J Am Coll Cardiol 13:1653–1665, 1989.
Garza D, Sease DR, Merhige ME, Hicks K, Mullans N, Gould KL. Noninvasive identification of viable vs. infarcted myocardium by automated three dimensional cardiac positron emission tomography with generator-produced rubidium-82 (abstr). J Nucl Med 30:865, 1989.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Patterson, R.E., Horowitz, S.F., Eisner, R.L. (1996). Comparison of Cost-Effectiveness of Myocardial Perfusion Imaging Versus other Approaches: Predictions by a Model. In: Schwaiger, M. (eds) Cardiac Positron Emission Tomography. Developments in Cardiovascular Medicine, vol 165. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1233-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1233-8_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8524-3
Online ISBN: 978-1-4613-1233-8
eBook Packages: Springer Book Archive